Stocktoria
Celldex Therapeutics, Inc. CLDX
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1986-05-15
Celldex Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Martin Samuel Bates | SVP AND CFO | 2026-01-02 | Option exercise | 4,817 | $10.38 |
| PEPIN RONALD | SR. VP & CBO | 2025-12-15 | Option exercise | 8,333 | $9.02 |
| PEPIN RONALD | SR. VP & CBO | 2025-12-15 | Option exercise | 11,000 | $2.78 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | 2025-12-04 | Sell | 4,166 | $29.09 |
| Wright Richard M. | 2025-11-13 | Option exercise | 6,876 | $9.02 | |
| Wright Richard M. | 2025-11-13 | Option exercise | 26,672 | $10.38 | |
| Wright Richard M. | 2025-11-13 | Option exercise | 15,750 | $22.48 | |
| Wright Richard M. | 2025-11-13 | Sell | 49,298 | $24.00 |
Source: SEC EDGAR filings · CIK 0000744218 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.